Monthly Archives: May 2018

The EVP of NeoGenomics (NASDAQ: NEO) is Selling Shares

Today, the EVP of NeoGenomics (NASDAQ: NEO), Steven C. Jones, sold shares of NEO for $1.98M. Following Steven C. Jones’ last NEO Sell transaction on May 03, 2016, the stock climbed by 3.5%. In addition to Steven C. Jones, 4

A Director at Limelight Networks (NASDAQ: LLNW) is Buying Shares

Today, a Director at Limelight Networks (NASDAQ: LLNW), David Peterschmidt, bought shares of LLNW for $61K. Following this transaction David Peterschmidt’s holding in the company was increased by 11.24% to a total of $889.4K. Following David Peterschmidt’s last LLNW Buy

Cowen & Co. Assigns a Buy Rating on Galapagos NV

Cowen & Co. analyst Phil Nadeau assigned a Buy rating to Galapagos NV (NASDAQ: GLPG) yesterday. The company’s shares opened today at $101.83. According to TipRanks.com, Nadeau is a 5-star analyst with an average return of 15.1% and a 57.9%

Cantel Medical Corp Receives a Hold from Needham

In a report released today, Michael Matson from Needham assigned a Hold rating to Cantel Medical Corp (NYSE: CMD). The company’s shares opened today at $109.09. Matson noted: “CMD’s F3Q18 revenue missed and EPS met consensus. Overall organic revenue growth

Cowen & Co. Believes Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) Still Has Room to Grow

Cowen & Co. analyst Ritu Baral assigned a Buy rating to Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) today. The company’s shares opened today at $265.61, close to its 52-week high of $273.19. According to TipRanks.com, Baral is a top 25 analyst

A Director at EQT Midstream (NYSE: EQM) is Buying Shares

Today, a Director at EQT Midstream (NYSE: EQM), Michael Bryson, bought shares of EQM for $55.53K. This recent transaction increases Michael Bryson’s holding in the company by 31.5% to a total of $232.6K. See today’s analyst top recommended stocks >>